NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering

Bend Bioscience and QHP Capital (”QHP”), the management company for NovaQuest Private Equity (“NQPE”), have announced plans to invest in a new operation in Bend, Oregon, an emerging hub of biotechnology R&D and manufacturing.  The Bend Bioscience team, as part of CoreRx, will focus on drug delivery R&D partnerships, product development, and early phase manufacturing for enhanced formulations utilizing particle engineering-based drug delivery technologies.  “This is an exciting development,” says Ajay Damani, CEO of CoreRx and Bend Bioscience, “with Bend Bioscience adding a new dimension of technology and innovation capabilities to CoreRx’s existing foundation of product development and manufacturing solutions.”